Fig. 7From: The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytesGlucose and lactate levels in the media of iPSC-derived cardiomyocytes following 48 h treatment with trastuzumab. Standard deviation (SD) calculated from three replicates. Glucose levels were significantly higher in the media of iPSC-derived cardiomyocytes treated with trastuzumab relative to untreated cells, *p = 0.004. Levels of lactate were not significantly different between iPSC-derived cardiomyocytes treated with trastuzumab and untreated cell, p = 0.329Back to article page